Safety of Anti-Immunoglobulin E Therapy With Omalizumab in Allergic Patients at Risk of Geohelminth Infection
Clinical and Experimental Allergy - United Kingdom
doi 10.1111/j.1365-2222.2007.02650.x
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2007
Authors
Publisher
Wiley